Trinitas Capital: Funding, Team & Investors | Startup Intros

Loading organizations...

Trinitas Capital: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
May 22, 2021	HiberCell	$97.4M Debt / Series B	—	ARCH Venture Partners, Bristol Myers Squibb, Hercules Capital, Huizenga Capital Management, Magnetic Ventures, Rene Mora, Mount Sinai Innovation Partners, Tekla Capital Management
Apr 1, 2019	Vividion Therapeutics	$82.0M Series B	Jakob Loven	ARCH Venture Partners, Canaan Partners, Cure Ventures, Earlybird Venture Capital, Nextech Invest, venBio, Versant Ventures, Vivo Capital, Alexandria Venture Investments, Altitude Life Science Ventures, BVF Partners, Cardinal Partners, Casdin Capital, Celgene, Mirae Asset Capital, Mubadala Capital
Feb 21, 2018	ORIC Pharmaceuticals	$50.0M Series C	—	EcoR1 Capital, Fidelity Management & Research Company, Foresite Capital, Kravis Investment Partners, Memorial Sloan Kettering Cancer Center, NS Investment, OrbiMed, Taiho Ventures, The Column Group, Topspin Fund
Sep 1, 2017	Gritstone bio	$93.0M Series B	Judith Li	Aisling Capital, Avoro Ventures, General Atlantic, GV, OrbiMed, The Column Group, Versant Ventures, Alexandria Venture Investments, Clarus Ventures, Frazier Healthcare Partners
Mar 1, 2016	Quanterix	$46.0M Series D	ARCH Venture Partners, Bihua Chen, Trinitas Capital	Lux Capital, David R. Walt, Bain Capital Ventures, Hercules Capital, Tufts University